Bonipar for Acute and Chronic Musculoskeletal Pain

Chronic Pain Clinical Trial

Official title: Efficacy of a Topical Pain Relief Spray Containing Herbal Oil Extracts (Bonipar) Among Individuals With Acute and Chronic Musculoskeletal Pain

Status Completed

Clinical Trial Summary

This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5%.

Clinical Trial Description

This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5% (approved by the FDA as a topical analgesic). Approximately 168 Duke patients will be recruited from Duke Pain Clinic, and selected Duke primary care practices. Individuals who report acute (less than 3 months duration) or chronic musculoskeletal pain of any intensity will be considered for enrollment into the study. After obtaining consent, eligible subjects will be will be randomized to receive Bonipar or diclofenac topical solution 1.5%. ;

Related Conditions & MeSH terms

• Chronic Pain
• Musculoskeletal Pain

• NCT number: NCT03471507
• Study type: Interventional
• Source: Duke University
• Status: Completed
• Phase: Phase 2
• Start date: December 15, 2020
• Completion date: September 22, 2022